IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 198 participants.
Also called NCT07473960
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 198 participants
- Registry
-
NCT07473960
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT07473960. Randomized; single masking; primary purpose treatment. Start 2026-04-01 (actual); primary completion 2026-08-26 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- Condition
- Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia
- Intervention (Drug)
- IBI306
- Intervention (Drug)
- placebo
- Intervention (Drug)
- placebo
- Intervention (Drug)
- IBI306
- Lead sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
Record details
- Record id
cardio:ct-nct07473960- Content hash
cbd9d58d857b003b59b48e1de3ee2f4b1a473c01d91a0834860d36de25e2a61f